References
Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H (2008) Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 108:137–149. doi:10.1007/s10549-007-9586-8
Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR (2005) Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomark Prev 14:1998–2003. doi:10.1158/1055-9965.EPI-05-0076
Zaletayev D, Artamonov V, Mikhaylenko D, Lyubchenko L, Nemtsova M (2005) DNA polymorphisms of several genes and predisposition to breast cancer. Breast Cancer Res 7:S21–S22. doi:10.1186/bcr1100
Smith TR, Levine EA, Perrier ND, Miller MS, Freimanis RI, Lohman K, Case LD, Xu JF, Mohrenweiser HW, Hu JJ (2003) DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomark Prev 12:1200–1204
Wittke-Thompson JK, Pluzhnikov A, Cox NJ (2005) Rational inferences about departures from Hardy–Weinberg equilibrium. Am J Hum Genet 76:967–986. doi:10.1086/430507
Frank B, Rigas SH, Bermejo JL, Wiestler M, Wagner K, Hemminki K, Reed MW, Sutter C, Wappenschmidt B, Balasubramanian SP, Meindl A, Kiechle M, Bugert P, Schmutzler RK, Bartram CR, Justenhoven C, Ko YD, Bruning T, Brauch H, Hamann U, Pharoah PP, Dunning AM, Pooley KA, Easton DF, Cox A, Burwinkel B (2008) The CASP8-652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat 111:139–144. doi:10.1007/s10549-007-9752-z
Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, Wu PE, Shen CY (2008) Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res Treat 111:145–155. doi:10.1007/s10549-007-9754-x
Justenhoven C, Pierl CB, Haas S, Fischer HP, Baisch C, Hamann U, Harth V, Pesch B, Bruning T, Vollmert C, Illig T, Dippon J, Ko YD, Brauch H (2008) The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer. Breast Cancer Res Treat 111:171–177. doi:10.1007/s10549-007-9762-x
Gyorffy B, Kocsis I, Vasarhelyi B (2004) Missed calculations and new conclusions: re-calculation of genotype distribution data published in Journal of Investigative Dermatology, 1998–2003. J Invest Dermatol 122:644–646. doi:10.1111/j.0022-202X.2004.22334.x
Deng HW, Chen WM, Recker RR (2001) Population admixture: detection by Hardy–Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics 157:885–897
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, KD., Di, GH., Fan, L. et al. Test of Hardy–Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions. Breast Cancer Res Treat 117, 675–677 (2009). https://doi.org/10.1007/s10549-009-0353-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-009-0353-x